newsfilter
← Latest News
Business Wire·

Transgene and BioInvent Have Enrolled First Patient in Phase I/IIa Trial of Novel Oncolytic Virus BT-001 in Solid Tumors

STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News: